Palivizumab for respiratory syncytial virus prophylaxis

Journal of Pediatric Health Care

Volumn 13, Issue 4, 1999, Pages 191-195

  Sandritter, Tracy ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PALIVIZUMAB;

HUMAN; INFANT; PATIENT SELECTION; PEDIATRIC NURSING; PRESCHOOL CHILD; REVIEW; TREATMENT OUTCOME; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; PATIENT SELECTION; PEDIATRIC NURSING; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 9944235581     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5245(99)90039-1     Document Type: Article

References (15)

1. American Academy of Pediatrics, Committee on Infectious Disease, Committee on Fetus and Newborn. (1997). Respiratory syncytial virus immune globulin intravenous: Indications for use. Pediatrics, 99(4), 645-650.
2. American Academy of Pediatrics, Committee on Infectious Disease, Committee on Fetus and Newborn. (1998). Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics, 102(5), 1211-1216.
3. Beeler, J. A., & Coelingh, K. V. (1989). Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: Effect of mutation upon fusion function. Journal of Virology, 63(7), 2941-2950.
4. Groothuis, J. R., Simoes, E. A. F., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., Tristram, D. A., Siber, G. R., Prince, G. A., Van Raden, M., Hemming, V. G., & the RSVIG study group. (1993). Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. New England Journal of Medicine, 329, 1524-1530.
5. Impact-RSV Study Group. (1998). Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 102(3), 531-537.
6. Johnson, S., Oliver, C., Prince, G. A., Hemming, V. G., Pfarr, D. S., Wang, S., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J. K., Woods, R., Bansal, G., Couchenour, D., Tsao, E., Hall, W. C., & Young, J. F. (1997). Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. Journal of Infectious Disease, 176, 1215-1224.
7. Karron, R. A., & Ambrosino, D. M. (1998). Respiratory syncytial virus vaccines. Pediatric Infectious Disease Journal, 17(10), 919-920.
8. MMWR, Morbidity and Morality Weekly Report. (1998). Update: Respiratory syncytial virus activity - United States, 1997-1998 season. MMWR, 47(48), 1043-1045.
9. PREVENT Study Group. (1997). Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory synctytial virus immune globulin prophylaxis. Pediatrics, 99(1), 93-99.
10. Product Information. (1998). Palivizumab. Gaithersburg, MD: MedImmune, Inc.
11. Saez-Llorens, X., Castano, E., Null, D., Steichen, J, Sanchez, P. J., Ramilo, O., Top, F. H., Connor, E., & the MEDI-493 Study Group. (1998). Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. Pediatric Infectious Disease Journal, 17(9), 787-791.
12. Sandritter, T. L., & Kraus, D. M. (1997). Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part I. Journal of Pediatric Health Care, 11(6), 284-293.
13. Sandritter, T. L., & Kraus, D. M. (1998). Respiratory syncytial virus-immunoglobulin intravenous (RSV-IGIV) for respiratory syncytial viral infections: Part II. Journal of Pediatric Health Care, 12(2), 85-92.
14. Storch, G. A. (1998). Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics, 102(3), 648-651.
15. Subramanian, K. N. S., Weisman, L. E., Rhodes, T., Ariagno, R., Sanchez, P. J., Steichen, J., Givner, L. B., Jennings, T. L., Top, F. H., Carlin, D., Connor, E., & the MEDI-493 Study Group. (1998). Pediatric Infectious Disease Journal, 17(2), 110-115.